Circulating microRNAs, potential biomarkers for drug-induced liver injury
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Drug-induced liver injury is a frequent side effect of many drugs, constitutes a significant threat to patient health and has an enormous economic impact on health care expenditures. Numerous efforts have been made to identify reliable and predictive markers to detect the early signs of drug-induced injury to the liver, one of the most vulnerable organs in the body. These studies have, however, not delivered any more informative candidates than the serum aminotransferase markers that have been available for ≈30 years. Using acetaminophen overdose-induced liver injury in the mouse as a model system, we have observed highly significant differences in the spectrum and levels of microRNAs in both liver tissues and in plasma between control and overdosed animals. Based on our survey of microRNA expression among normal tissues, some of the microRNAs, like messenger RNAs, display restricted tissue distributions. A number of elevated circulating microRNAs in plasma collected from acetaminophen-overdosed animals are highly expressed in the liver. We have demonstrated that specific microRNA species, such as mir-122 and mir-192, both are enriched in the liver tissue and exhibit dose- and exposure duration-dependent changes in the plasma that parallel serum aminotransferase levels and the histopathology of liver degeneration, but their changes can be detected significantly earlier. These findings suggest the potential of using specific circulating microRNAs as sensitive and informative biomarkers for drug-induced liver injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, the potential of the 3D hLiMT to report on the release of novel translational in vivo liver hepatotoxicity biomarkers, miR-122, a highly liver specific microRNA (Wang et al. 2009), HMGB1, a marker of immune modulation and necrosis (Antoine et al. 2009), and α-GST, a sensitive, highly specific and early biomarker for hepatocellular injury (Muller and Dieterle 2009), following exposure”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Wang et al. 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969 · cited 3×
“Recent findings suggest that circulating miRNAs may be plasma biomarkers for the diagnosis of lung (23), colorectal (23), and prostate cancers (22).”
BackgroundChen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560 · cited 2×
“Recent findings suggest that circulating miRNAs may be plasma biomarkers for the diagnosis of lung (23), colorectal (23), and prostate cancers (22).”
BackgroundSelf-citationLee, Y. S., & Dutta, A. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092222 · Cited by 1,505
The current state of serum biomarkers of hepatotoxicity
Ozer, J., Ratner, M., Shaw, M., Bailey, W., & Schomaker, S. (2008) · Toxicology · doi:10.1016/j.tox.2007.11.021 · Cited by 1,269 · cited 1×
“Many studies have been conducted to identify more reliable and sensitive early blood markers for liver injury by using various high throughput technologies such as protein mass spectrometry and gene expression arrays (3, 4).”
BackgroundCharacterization of microRNA expression profiles in normal human tissues.
Liang, Y., Ridzon, D., Wong, L., & Chen, C. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-166 · Cited by 881
Chang, J., Nicolas, E., Marks, D., Sander, C., Lerro, A., Buendia, M. A., Xu, C., Mason, W. S., Moloshok, T., Bort, R., et al. (2004) · RNA Biology · doi:10.4161/rna.1.2.1066 · Cited by 811 · cited 1×
“In contrast, some of the affected circulating miRNAs by acetaminophen overdosing, as demonstrated in our study, are highly restricted to the liver, such as mir-122 (32).”
BackgroundN-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency
Atkuri, K. R., Mantovani, J. J., Herzenberg, L. A., & Herzenberg, L. A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.005 · Cited by 721 · cited 1×
“N-acetylcysteine (NAC) is an amino acid derivative that can be quickly converted into intracellular GSH in the body (10).”
BackgroundAcetaminophen Poisoning and Toxicity
Rumack, B. H., & Matthew, H. (1975) · Pediatrics · doi:10.1542/peds.55.6.871 · Cited by 640 · cited 1×
“The levels of acetaminophen in the blood combined with the Rumack–Matthew nomogram, a diagram to assess the risk of hepatotoxicity based on blood acetaminophen concentration (14), can also be used as guidance to predict tissue injury (15).”
MethodLarson, A. M. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.06.006 · Cited by 451
Acetaminophen-induced nephrotoxicity: Pathophysiology, clinical manifestations, and management
Mazer, M., & Perrone, J. (2008) · Journal of Medical Toxicology · doi:10.1007/bf03160941 · Cited by 396 · cited 1×
“Tissue injuries other than in the liver have also been reported in acetaminophen overdose (27).”
BackgroundContribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation
MANYIKE, P., KHARASCH, E., KALHORN, T., & SLATTERY, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.104736 · Cited by 355 · cited 4×
“In conditions such as acute acetaminophen overdose, where the level of GSH in the cell is insufficient to eliminate all of the toxic metabolite, the excess intracellular NAPQI forms cysteine adducts on various macromolecules, disrupts numerous critical cellular functions, and elevates innate immune responses (9), whic…”
BackgroundInfluentialLiu, Z.-X., Govindarajan, S., & Kaplowitz, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.053 · Cited by 328 · cited 1×
“In conditions such as acute acetaminophen overdose, where the level of GSH in the cell is insufficient to eliminate all of the toxic metabolite, the excess intracellular NAPQI forms cysteine adducts on various macromolecules, disrupts numerous critical cellular functions, and elevates innate immune responses (9), whic…”
BackgroundOxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by Human CYP3A4
Thummel, K. E., Lee, C. A., Kunze, K. L., Nelson, S. D., & Slattery, J. T. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90295-8 · Cited by 296 · cited 4×
“In conditions such as acute acetaminophen overdose, where the level of GSH in the cell is insufficient to eliminate all of the toxic metabolite, the excess intracellular NAPQI forms cysteine adducts on various macromolecules, disrupts numerous critical cellular functions, and elevates innate immune responses (9), whic…”
BackgroundInfluentialReview article: drug hepatotoxicity
CHANG, C. Y., & SCHIANO, T. D. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03307.x · Cited by 264
Martinez Elizondo, P. (1952) · PubMed · Cited by 135
Anundi, I., Lähteenmäki, T., Rundgren, M., Moldeus, P., & Lindros, K. O. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90277-4 · Cited by 120 · cited 1×
“Acetaminophen overdose induces injuries primarily to centrilobular hepatocytes because of the enrichment of cytochrome P450 isozymes for bioactivation and less intercellular GSH for detoxification (33).”
BackgroundA simple array platform for microRNA analysis and its application in mouse tissues
Tang, X., Gal, J., Zhuang, X., Wang, W., Zhu, H., & Tang, G. (2007) · RNA · doi:10.1261/rna.498607 · Cited by 116 · cited 1×
“The miRNA expression levels in liver tissues were distributed over 4 orders of magnitude, and a significant number of miRNAs were either not expressed or expressed at very low levels as described (24, 25).”
BackgroundAcetaminophen safety and hepatotoxicity – where do we go from here?
Amar, P. J., & Schiff, E. R. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.4.341 · Cited by 112 · cited 1×
“If misused, either intentionally or accidentally, acetaminophen can cause significant liver injury (5, 6).”
BackgroundThe perfect storm of tiny RNAs
Ruvkun, G. (2008) · Nature Medicine · doi:10.1038/nm1008-1041 · Cited by 111 · cited 1×
“It is believed that miRNAs primarily affect the stability of mRNA and/or the initiation and progression of protein translation, but broader regulatory roles have been suggested (18, 19).”
BackgroundBell, H. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91833-x · Cited by 99
James, O., Roberts, S. H., Douglas, A., Lesna, M., Pulman, L., Smith, P., & Watson, A. J. (1975) · The Lancet · doi:10.1016/s0140-6736(75)90170-1 · Cited by 96 · cited 1×
“The most commonly used diagnostic test for acetaminophen overdose is to determine the activity of certain hepatocellular enzymes, aspartate aminotransferase (AST or SGOT) and alanine aminotransferase (ALT or SGPT), in the blood (12).”
BackgroundAmacher, D. E., Adler, R., Herath, A., & Townsend, R. R. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.049908 · Cited by 92 · cited 1×
“Many studies have been conducted to identify more reliable and sensitive early blood markers for liver injury by using various high throughput technologies such as protein mass spectrometry and gene expression arrays (3, 4).”
BackgroundAdvances, Challenges, and Limitations in Serum-Proteome-Based Cancer Diagnosis
Ebert, M. P. A., Korc, M., Malfertheiner, P., & Röcken, C. (2005) · Journal of Proteome Research · doi:10.1021/pr050271e · Cited by 76 · cited 1×
“Challenges for developing protein-based biomarkers from body fluids, such as plasma, serum, and urine, include the complexity of protein composition, the assorted posttranslational modifications, the low abundance of proteins of interest, the difficulty of developing suitable high-affinity capture agents, the complexi…”
MethodDamsten, M. C., Commandeur, J. N. M., Fidder, A., Hulst, A. G., Touw, D. J., Noort, D., & Vermeulen, N. P. E. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.014233 · Cited by 66 · cited 1×
“However, the protein adducts are measured by high-performance liquid chromatography or mass spectrometry (17) and are not used routinely in most clinics.”
BackgroundMicroRNA Signatures as Diagnostic and Therapeutic Targets
Waldman, S. A., & Terzic, A. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105353 · Cited by 50 · cited 1×
“Discussion Besides being recognized as key molecules in intracellular regulatory networks for gene expression, the spectra and levels of some miRNAs are emerging as biomarkers for various pathological conditions (26).”
Background?Liver function tests? are not always tests of liver function
Korones, D. N., Brown, M. R., & Palis, J. (2001) · American Journal of Hematology · doi:10.1002/1096-8652(200101)66:1<46::aid-ajh1007>3.0.co;2-o · Cited by 47 · cited 1×
“Even though ALT is fairly abundant in the liver, and elevated levels in the plasma usually imply hepatic injuries or diseases, elevated ALT levels from extrahepatic sources have been reported from patients with burns (28) or individuals with muscle inflammation (29), hypothyrodism (30), or myopathies (31).”
BackgroundDoes the patient history predict hepatotoxicity after acute paracetamol overdose?
Waring, W. S., Robinson, O. D. G., Stephen, A. F., Dow, M., & Pettie, J. M. (2008) · QJM · doi:10.1093/qjmed/hcm139 · Cited by 47 · cited 1×
“Ideally, the patient may disclose the amount ingested and the time of ingestion; however, this information is often unreliable (13).”
BackgroundThe art of microRNA: Various strategies leading to gene silencing via an ancient pathway
Tang, G., Tang, X., Mendu, V., Tang, X., Jia, X., CHEN, Q., & HE, L. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.06.006 · Cited by 45 · cited 1×
“It is believed that miRNAs primarily affect the stability of mRNA and/or the initiation and progression of protein translation, but broader regulatory roles have been suggested (18, 19).”
BackgroundDillhoff, M. E., Wojcik, S. E., & Bloomston, M. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.02.046 · Cited by 44 · cited 1×
“Even though the biological function of miRNA is yet to be fully understood, it has been shown that the tissue levels of specific miRNAs correlate well with the pathological development of several different cancers (20, 21).”
BackgroundAssessment and treatment of acetaminophen overdose.
Lewis, R. K., & Paloucek, F. P. (1991) · PubMed · Cited by 41
Acetaminophen protein adducts: A review
Bond, G. R. (2009) · Clinical Toxicology · doi:10.1080/15563650801941831 · Cited by 39 · cited 1×
“The level of plasma NAPQI-protein adducts correlates well with the serum aminotransferase levels and has been demonstrated as a good indicator for acetaminophen toxicity (16).”
BackgroundProteomics: Advances in Biomarker Discovery
Cowan, M. L., & Vera, J. H. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.1.21 · Cited by 31 · cited 1×
“Challenges for developing protein-based biomarkers from body fluids, such as plasma, serum, and urine, include the complexity of protein composition, the assorted posttranslational modifications, the low abundance of proteins of interest, the difficulty of developing suitable high-affinity capture agents, the complexi…”
MethodDrug-induced hepatotoxicity in humans.
Marzio, D. H., & Navarro, V. J. (2008) · PubMed · Cited by 26
Halkes, S. B. A., van den Berg, A. J. J., Hoekstra, M. J., du Pont, J. S., & Kreis, R. W. (2002) · Burns · doi:10.1016/s0305-4179(02)00041-4 · Cited by 20 · cited 1×
“Even though ALT is fairly abundant in the liver, and elevated levels in the plasma usually imply hepatic injuries or diseases, elevated ALT levels from extrahepatic sources have been reported from patients with burns (28) or individuals with muscle inflammation (29), hypothyrodism (30), or myopathies (31).”
BackgroundHarr, K. E., Allison, K., Bonde, R. K., Murphy, D., & Harvey, J. W. (2008) · Journal of Zoo and Wildlife Medicine · doi:10.1638/2007-0134r.1 · Cited by 12 · cited 1×
“Even though ALT is fairly abundant in the liver, and elevated levels in the plasma usually imply hepatic injuries or diseases, elevated ALT levels from extrahepatic sources have been reported from patients with burns (28) or individuals with muscle inflammation (29), hypothyrodism (30), or myopathies (31).”
BackgroundShimoda, S.-I., & Kasai, K. (1980) · Folia Endocrinologica Japonica · doi:10.1507/endocrine1927.56.8_1096 · Cited by 4 · cited 1×
“Even though ALT is fairly abundant in the liver, and elevated levels in the plasma usually imply hepatic injuries or diseases, elevated ALT levels from extrahepatic sources have been reported from patients with burns (28) or individuals with muscle inflammation (29), hypothyrodism (30), or myopathies (31).”
BackgroundAcetaminophen Overdose and N-acetylcysteine Therapy
Chong, V.-H. (2007) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v36n8p704 · Cited by 2
Cited by
The MicroRNA Spectrum in 12 Body Fluids
Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., How Huang, K., Jen Lee, M., Galas, D. J., & Wang, K. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147405 · Cited by 2,477
Self-citationCharacterization of extracellular circulating microRNA
Turchinovich, A., Weiz, L., Langheinz, A., & Burwinkel, B. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr254 · Cited by 1,941
“In a similar way, increase in particular ‘tissue specific’ or ‘organ specific’ miRNAs in blood plasma (or other body fluids) could serve as an indication of toxicity of a particular tissue/organ (10,11).”
BackgroundCurrent and future perspectives of liquid biopsies in genomics-driven oncology
Heitzer, E., Haque, I. S., Roberts, C. E. S., & Speicher, M. R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0071-5 · Cited by 1,557
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., Mayr, A., Weger, S., Oberhollenzer, F., Bonora, E., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.226357 · Cited by 1,283
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
“In mice, mir-122 and mir-192 are enriched in liver tissue and exhibit dose- and exposure-dependent changes in plasma that parallel serum aminotransferase levels and the histopathology of liver degeneration.(300) In human acetaminophen-induced liver injury, miR-122, miR-192-5p and other miRNAs are elevated, but further…”
Background
Metadata
- Authors
- Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J.
- Affiliations
- Institute for Systems Biology (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-03-17
- Volume
- 106
- Issue
- 11
- Pages
- 4402-4407
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2657429
- OpenAlex
- W2111848990
- Cited by
- 1,149
- References
- 37
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 33 · 2023: 41 · 2022: 24 · 2021: 40 · 2020: 64 · 2019: 56 · 2018: 81 · 2017: 80 · 2016: 91 · 2015: 97 · 2014: 121 · 2013: 116 · 2012: 101
- FWCI
- 81.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense (W911SR-07-C-0101)
- Battelle
- National Institutes of Health (W911SR-07-C-0101)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- drug-induced liver injury, circulating microRNAs, biomarkers, acetaminophen overdose, miR-122, miR-192, plasma microRNA, transaminases, liver histopathology
- MeSH terms
- Acetaminophen, Animals, Humans, Liver, Liver Circulation, Liver Diseases, Tissue Distribution, Biomarkers, MicroRNAs, Mice, Chemical and Drug Induced Liver Injury, Drug Overdose, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.